Mundeep Kaur Kainth

Dr. Mundeep Kaur Kainth

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Pediatrics
Verified
Journal Article
Open access
PDF file
MKMundeep Kaur Kainth
Mundeep Kaur Kainth
PGPratichi K. Goenka
Pratichi K. Goenka
KWKristy A. Williamson
Kristy A. Williamson
JFJoanna S. Fishbein
Joanna S. Fishbein
MSMd Anupama Subramony
Md Anupama Subramony
NCNORTHWELL HEALTH COVID-19 RESEARCH CONSORTIUM
NORTHWELL HEALTH COVID-19 RESEARCH CONSORTIUM
We aim to describe the demographics, clinical presentation, hospital course, and severity of pediatric inpatients with coronavirus disease 2019 (COVID-19), with an emphasis on healthy, immunocompromised, and chronically ill children. We conducted a single-center retrospective cohort study of hospitalized children aged younger than 22 years with COVID-19 infection at Steven and Alexandra Cohen Children’s Medical Center at Northwell Health. Cases were identified from patients with fever and/or respiratory symptoms who underwent a nucleic acid amplification–based test for severe acute respiratory syndrome coronavirus 2. Sixty-five patients were identified. The median age was 10.3 years (interquartile range, 1.4 months to 16.3 years), with 48% of patients older than 12 years and 29% of patients younger than 60 days of age. Fever was present in 86% of patients, lower respiratory symptoms or signs in 60%, and gastrointestinal symptoms in 62%. Thirty-five percent of patients required ICU care. The white blood cell count was elevated in severe disease (P = .0027), as was the C-reactive protein level (P = .0192), compared with mild and moderate disease. Respiratory support was required in 34% of patients. Severity was lowest in infants younger than 60 days of age and highest in chronically ill children; 79% of immunocompromised children had mild disease. One death was reported. Among children who are hospitalized for COVID-19, most are younger than 60 days or older than 12 years of age. Children may have severe infection requiring intensive care support. The clinical course of immunocompromised patients was not more severe than that of other children. Elevated white blood cell count and C-reactive protein level are associated with greater illness severity.

1 March 2021 in Access Microbiology
Verified
Journal Article
Open access
AKAkshay M. Khatri
Akshay M. Khatri
SRShipra Rai
Shipra Rai
CSCaroline Shank
Caroline Shank
AMAlissa McInerney
Alissa McInerney
BKBlanka Kaplan
Blanka Kaplan
MKMundeep Kaur Kainth
Mundeep Kaur Kainth
Introduction. Bacillus clausii as a probiotic supplement is increasingly used in both adult and paediatric patient populations. There is limited awareness about potential adverse effects. Case presentation. We report a case of prolonged (111 days) B. clausii bacteraemia after brief probiotic use in a 17-month-old immunocompetent child, without a definite focus of infection and in the absence of predisposing risk factors or underlying co-morbidities. We identified seven probiotic use-associated cases of prolonged B. clausii bacteraemia (mean duration [range] 64 days [14–93 days] where data were available) in the literature, all with underlying co-morbidities. Conclusion. B. clausii probiotic preparations may cause prolonged bacteraemia, rendering patients with underlying co-morbidities as well as those with unrecognized risk factors vulnerable for significant infectious complications.

11 January 2022 in Viruses
Verified
Journal Article
Open access
PDF file
MKMundeep Kaur Kainth
Mundeep Kaur Kainth
JFJoanna S. Fishbein
Joanna S. Fishbein
TATeresa Aydillo
Teresa Aydillo
AEAlba Escalera
Alba Escalera
RORachael Odusanya
Rachael Odusanya
CDClifford S. Deutschman
Clifford S. Deutschman
The most effective intervention for influenza prevention is vaccination. However, there are conflicting data on influenza vaccine antibody responses in obese children. Cardio-metabolic parameters such as waist circumference, cholesterol, insulin sensitivity, and blood pressure are used to subdivide individuals with overweight or obese BMI into ‘healthy’ (MHOO) or ‘unhealthy’ (MUOO) metabolic phenotypes. The ever-evolving metabolic phenotypes in children may be elucidated by using vaccine stimulation to characterize cytokine responses. We conducted a prospective cohort study evaluating influenza vaccine responses in children. Participants were identified as either normal-weight children (NWC) or overweight/obese using BMI. Children with obesity were then characterized using metabolic health metrics. These metrics consisted of changes in serum cytokine and chemokine concentrations measured via multiplex assay at baseline and repeated at one month following vaccination. Changes in NWC, MHOO and MUOO were compared using Chi-square/Fisher’s exact test for antibody responses and Kruskal–Wallis test for cytokines. Differences in influenza antibody responses in normal, MHOO and MUOO children were statistically indistinguishable. IL-13 was decreased in MUOO children compared to NWC and MHOO children (p = 0.04). IL-10 approached a statistically significant decrease in MUOO compared to MHOO and NWC (p = 0.07). Influenza vaccination does not provoke different responses in NCW, MHOO, or MUOO children, suggesting that obesity, whether metabolically healthy or unhealthy, does not alter the efficacy of vaccination. IL-13 levels in MUO children were significantly different from levels in normal and MHOO children, indicating that the metabolically unhealthy phenotypes may be associated with an altered inflammatory response. A larger sample size with greater numbers of metabolically unhealthy children may lend more insight into the relationship of chronic inflammation secondary to obesity with vaccine immunity.

1 September 2014 in The Journal of Pediatrics
Verified
Journal Article
Closed access
MKMundeep Kaur Kainth
Mundeep Kaur Kainth
FGFrancis Gigliotti
Francis Gigliotti

11 April 2024 in Vaccine
Verified
Journal Article
Open access
MKMundeep Kaur Kainth
Mundeep Kaur Kainth
GSGrace Sembajwe
Grace Sembajwe
HAHeejoon Ahn
Heejoon Ahn
MQMin Qian
Min Qian
MCMaxine Carrington
Maxine Carrington
SJSophia Jan
Sophia Jan
Healthcare personnel (HCP) are important messengers for promoting vaccines, for both adults and children. Our investigation describes perceptions of fully vaccinated HCP about COVID-19 vaccine for themselves and primary series for their children. To determine associations between sociodemographic, employment characteristics and perceptions of COVID-19 vaccines among HCP overall and the subset of HCP with children, who were all mandated to receive a COVID-19 vaccine, in a large US metropolitan region. Cross-sectional survey of fully vaccinated HCP from a large integrated health system. Participants were electronically enrolled within a multi-site NYS healthcare system from December 21, 2021, to January 21, 2022. Of 78,000 employees, approximately one-third accessed promotional emails; 6,537 employees started surveys and 4165 completed them. Immunocompromised HCP (self-reported) were excluded. We conducted a survey with measures including demographic variables, employment history, booster status, child vaccination status; vaccine recommendation, confidence, and knowledge. The primary outcome was COVID-19 vaccine hesitancy for all dose types - primary series or booster doses - among HCP. Findings from 4,165 completed surveys indicated that almost 17.2 % of all HCP, including administrative and clinical staff, were hesitant or unsure about receiving a COVID-19 vaccine booster, despite the NYS recommendation to do so. Depending on age group, between 20 % and 40 % of HCP were hesitant about having their children vaccinated for COVID-19, regardless of clinical versus non-clinical duties. In multivariable regression analyses, lack of booster dose, unvaccinated children, females, income less than $50,000, and residence in Manhattan remained significantly associated with vaccine hesitancy. Despite mandated COVID-19 vaccination, a substantial proportion of HCP remained vaccine hesitant towards adult booster doses and pediatric COVID-19 vaccination. While provider recommendation has been the mainstay of combatting COVID-19 vaccine hesitancy, a gap exists between HCP-despite clinical or administrative status-and the ability to communicate the need for vaccination in a healthcare setting. While previous studies describe the HCP vaccine mandate as a positive force to overcome vaccine hesitancy, we have found that despite a mandate, there is still substantial COVID-19 vaccine hesitancy, misinformation, and reluctance to vaccinate children.

7 August 2019 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MBMorgan Birabaharan
Morgan Birabaharan
MKMundeep Kaur Kainth
Mundeep Kaur Kainth
AKAaron D. Kessel
Aaron D. Kessel
SHStefan H. F. Hagmann
Stefan H. F. Hagmann
Acute respiratory distress syndrome (ARDS) is seldom described as a complication of typhoid fever (TF). Only 13 cases have hitherto been reported in the English and non-English literature since 1990. We report an 8-year-old boy with TF after return from India who developed pediatric ARDS (pARDS) despite adequate antibiotic treatment. Among patients with available information including this case, we noted that most not born or raised in a TF-endemic country (4/6) compared with none (0/6) of the domestic cases in a TF-endemic country developed ARDS within 48 hours of starting the antibiotic treatment. Our case raises important questions regarding the frequency, pathophysiology, and appropriate management of ARDS and pARDS in patients with TF.